ABSTRACT: Flash autoclaving is one of the most frequently utilized methods of sterilizing devices, implants or other materials. For a number of decades, it has been common practice for surgeons to remove implantable devices, flash autoclave and then reimplant them in a patient. Data have not yet indicated the potential for biofilms to survive or remain on the surface of orthopaedic-relevant materials following flash autoclave. In this study, monomicrobial and polymicrobial biofilms were grown on the surface of clinically relevant titanium materials and exposed to flash autoclave settings that included varying times and temperatures. Data indicated that when the sterilization and control temperatures of an autoclave were the same, biofilms were able to survive flash autoclaving that was performed for a short duration. Higher temperature and increased duration rendered biofilms non-viable, but none of the autoclave settings had the ability to remove or disperse the presence of biofilms from the titanium surfaces. These findings may be beneficial for facilities, clinics, or hospitals to consider if biofilms are suspected to be present on materials or devices, in particular implants that have had associated infection and are considered for re-implantation. Published 2017. This article is a U.S. Government work and is in the public domain in the USA. J Orthop Res 36: 1543-1550, 2018. 
Periprosthetic infection that accompanies total joint replacement devices is a catastrophic outcome for patients, surgeons, and healthcare systems. [1] [2] [3] Biofilms are becoming of greater concern and have been shown to contribute to these infections, in particular those that prove difficult to treat. [4] [5] [6] [7] Antibiotic therapy is the first line of defense. However, revision surgeries with explantation of infected components, debridement of necrotic tissue and biofilm-procedures that give the host tissue a "fresh start" to improve the chances of future implant success-has become the most common approach toward eradication of infection.
For several decades, it has been common practice during revision surgery to remove an infected implant, flash autoclave (also referred to as immediate-use steam sterilization or IUSS) and replace the same implant in a patient after irrigation and tissue debridement. [8] [9] [10] [11] Autoclaving is a well-known and long-standing practice of sterilization across many fields. The primary rationale for flash autoclaving, or IUSS, in a clinical setting is to make instruments or devices available that may be needed in a timely fashion. It also provides benefit of reducing the time that a patient is under anesthesia and provides availability of an implant that is already known to be the correct size for that patient.
In 2015, the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) provided a health advisory network (HAN) advisory (HAN00382) 12 and follow-up advisory (HAN00383) 13 to highlight the importance of healthcare facilities to properly maintain, clean, and disinfect or sterilize reusable medical devices for public health need. The guideline was directed toward media reports and patient risk outcomes related to infections following endoscope use, but the principles apply to all reused devices and all sterilization procedures. For guidance, the HAN referred to the CDC's "Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008." 14 Within this guideline, it is noted that two sterilization temperatures, 121˚C or 132˚C, are commonly used to sterilize devices by autoclave with 132˚C being recommended for flash autoclaving for healthcare devices or instruments that are wrapped. Notably, a directive released by the Veterans Affairs in 2016 states that non-biological implantable devices are not to be sterilized by IUSS, and should be used primarily in cases of emergency. 15 Sterilization times and temperatures that are recommended have all been optimized for planktonic bacteria or spores and are well defined for liquids, solids, and devices. No guidelines on autoclave times or temperatures have been established for biofilms. Literature review reveals that preliminary analyses have been performed on cobalt chrome to determine ability of relatively immature biofilms to remain intact on orthopaedic-relevant surfaces following autoclaving. 16, 17 However, no data have been collected to assess biofilms on titanium materials or under flash autoclave conditions. Given that orthopaedic implants requiring treatment or revision for infection are likely to have surface biofilms present, 3, 5, 6, [18] [19] [20] these considerations are imperative.
In this study, it was hypothesized that wellestablished polymicrobial biofilms grown on the surface of commercially pure titanium orthopaedic implant materials would survive flash autoclaving. It was further hypothesized that flash autoclaving would not remove well-established biofilms from the clinically relevant material surfaces. More specifically, although flash autoclaving may have the ability to render biofilms non-viable, the potential exists for them to still be intact and present on a material surface. These data could have important influence for clinical applications.
MATERIALS AND METHODS

Supplies and Bacterial Isolates
Brain heart infusion (BHI) broth was purchased from Grainger (Lake Forest, IL). Tryptic soy broth (TSB) to make tryptic soy agar (TSA), medical grade detergent and other general lab supplies were purchased from Fisher Scientific (Waltham, MA). Smooth finished and porous coated commercially pure titanium materials were manufactured and acquired from three separate companies to diversify the testing. Manufacturing details are proprietary, but each followed the processes used for materials that are currently used clinically. Samples were cut into diamond-shaped coupons (see Coupon Machining). It is well-known that biofilm formation can be influenced by surface roughness and although details of the porous coating cannot be provided, testing was performed on smooth surfaces in addition to porous coatings in order to address potential influence of the materials' roughness. The CDC biofilm reactor and components were purchased from Biosurface Technologies (Bozeman, MT). A clinical isolate of methicillin-resistant Staphylococcus aureus (MRSA) and an American Type Culture Collection (ATCC) strain of Bacillus subtilis were used for biofilm growth and analysis. The MRSA isolate was cultured from a patient who suffered from knee infection and has been used in a variety of in vitro and in vivo models that have determined its pathogenic nature. 18, 19 B. subtilis ATCC 19659 was purchased from the ATCC (Manassas, VA).
Coupon Machining
Coupons of porous coated or smooth titanium were custom machined. A custom water saw with a diamond blade was first used to cut circular discs of commercially pure porous coated or smooth titanium in half (Fig. 1A) . Porous coatings were obtained from multiple companies with proprietary processes for creating the porous coating. These were cut further, then ground and polished by hand on grinding wheels such that each coupon had a diamond shape in order to maximize the number of coupons that could be made from each metal disc (Fig. 1B) . Coupons varied slightly in size, but were approximately 12.7 mm in width at the widest point, and approximately 3.2 mm height. Size variations did not affect the study objective. This shape allowed the coupons to be secured in a CDC reactor holder (Fig. 1C) . The coupon design allowed for growth of biofilms within the CDC biofilm reactor (Fig. 1D) .
Once machined, all coupons were passivated following a modified protocol of ASTM standard F86-04. In short, passivation was performed by cleaning and sonicating (42 kHz for 30 min) coupons in detergent, exposing them to a 35% nitric acid solution for 30-60 min and rinsing/sonicating them in reverse osmosis water for 30 min before loading into a reactor.
Biofilm Growth
To grow monomicrobial and polymicrobial biofilms, each of the bacterial isolates were first streaked individually from frozen stock onto tryptic soy agar (TSA) plates and incubated overnight at 37˚C. From the fresh culture, a 0.5 McFarland standard of each isolate was made (equated to $7.5 Â 10 7 colony forming units [CFU]/ml). One milliliter of a bacterial solution was inoculated into 500 ml of BHI and subsequently Figure 1 . Representative images of titanium materials and coupons that were cut to fit in the CDC biofilm reactor. (A) Circular disc with porous coated titanium that served as starting material for creating the coupons. Smooth titanium was also used to make smooth titanium coupons, but is not shown. (B) Coupons were cut into a triangular shape to maximize the number of coupons that could cut from the starting material in (A). (C) A porous coated and smooth titanium coupon inserted into a holder of the CDC biofilm reactor. The coupons were held in place by a threaded screw (arrow). A porous coated coupon is shown in the middle hole, and a smooth coupon is shown in the bottom hole. (D) CDC reactor holder with coupons placed inside of the biofilm reactor system. The baffle sitting behind the holder was used to create shear force that promoted biofilm growth. Ports on the top of the reactor allowed broth to be flowed into the reactor, and broth then exited the effluent port on the side of the glass vessel. poured aseptically into a CDC biofilm reactor. For monomicrobial biofilms, only MRSA was inoculated and for polymicrobial biofilms both isolates were inoculated.
The reactor was placed on a hot plate set at 40˚C (resulted in a broth temperature of $32˚C) and a baffle rotation of 130 rpm for 24 h. After the 24 h batch growth, a continuous flow of 10% BHI was flowed through the reactor at 6.94 ml/min for an additional 7 days. Following 8 total days of growth, biofilms on coupons were exposed to autoclaving.
The effect of flash autoclaving was tested against both monomicrobial and polymicrobial biofilms. The rationale for testing against both was twofold. First, the majority of bacilli, such as B. subtilis, are well-known for their matrix production. 21, 22 Furthermore, biofilms are known to have greater protection within a community that is "encased" in polymeric substance. [23] [24] [25] Thus, B. subtilis was included to help produce a robust matrix that would have potential to help the biofilm survive external perturbation. Second, orthopaedic-related infections are primarily monomicrobial in nature, but polymicrobial biofilms are likewise encountered. [26] [27] [28] Autoclave and Viability Analysis All data for the autoclave studies were collected using n ¼ 5 coupons/test. Following biofilm growth, coupons were exposed to one of three flash autoclave cycles that were run for 5 and 10 min, then assessed for viability. To determine the ability of biofilms to survive a flash autoclave cycle, coupons were aseptically removed from a coupon holder, placed in an autoclave pouch and exposed to one of three autoclave testing procedures. Notably, sterilization temperatures are commonly reported, yet what is not commonly reported is the control temperature setting of an autoclave. The control temperature is typically 2˚C higher and is important as it confirms that the sterilization temperature is maintained throughout an autoclave cycle.
In the first test, biofilms that had been grown on porous coated or smooth titanium were autoclaved for 5 and 10 min with the autoclave set at a control temperature of 121˚C and a sterilization temperature of 121˚C. In the second test, biofilms on both material types were autoclaved for 5 and 10 min with the autoclave set at a control temperature of 123˚C and a sterilization temperature of 121˚C. These first two temperature settings are primarily encountered in research lab settings, but are not uncommon to be used in clinical settings. In the third test, biofilms on both material types were autoclaved for 5 and 10 min with the autoclave set at a control temperature of 134˚C and sterilization temperature of 132˚C. The temperature setting in the third test reflected those that are recommended in the guideline and would be more commonly encountered in a clinical or hospital setting. It is recognized that autoclave settings and recommendations can vary broadly. The 5 min time setting was chosen to reflect a relatively short cycle, which would have greater potential to result in biofilm survival and thus reflected a higher risk situation. The 10 min time setting was chosen to reflect a cycle that would be more commonly used in a clinical setting. In all of the above-mentioned cases, the temperature in the autoclave was monitored by the readout display on the autoclave itself.
After autoclaving in any of the given cycles, a coupon was removed from an autoclave pouch, aseptically and gently placed into 2 ml of BHI, then incubated at 37˚C for 1.5 h. The rationale for incubating the biofilms for 1.5 h was to allow any potentially viable cells to recover from the autoclave process. After 1.5 h of incubation, coupons were vortexed for 1 min to shake biofilms off the surface of a material and into the BHI broth, then 0.5 ml of BHI was streaked onto TSA and incubated at 37˚C for up to 7 days. CFU, if present, were counted and calculated to determine CFU/coupon. Typically, sonication is used for this type of biofilm quantification process. In the case of biofilms that had been autoclaved, sonication was not used. Sonication is known to kill cells at over 100 kHz, and although the sonicator used in our lab runs at 42 kHz, which is not considered lethal to bacteria, with cells having been compromised by autoclaving it was considered that sonication may have been overly aggressive and run the risk of killing cells that had been traumatized.
To provide a baseline of CFU/coupon, a subset of coupons served as positive controls of growth. These were not exposed to autoclaving. Rather, following growth, coupons were vortexed for 1 min, sonicated for 10 min, vortexed for an additional 10 s then quantified using a 10-fold dilution series. From each dilution, 50 ml of solution were spot plated on TSA, incubated overnight and the number of colonies counted the following day to calculate CFU/coupon. Growth results were analyzed statistically using a one-way ANOVA with alpha level set at 0.05.
Autoclave and Biofilm Presence Analysis
In addition to determining the ability of biofilms to survive flash autoclave cycles, it was also determined whether biofilms would still be intact/present on the surface of either porous coated or smooth titanium surfaces following flash autoclave. To do so, the same biofilm growth and autoclave procedures as above were followed, the difference being that after being autoclaved, a coupon was removed from an autoclave pouch and placed directly into 2 ml of modified Karnovsky's fixative (2% paraformaldehyde, 2.5% glutaraldehyde in PBS buffered to pH 7.2-7.4). Coupons were fixed for a minimum of 2 h, placed in 100% ethanol for a minimum of 2 h, then air dried. Once dry, coupons were coated using a Hummer 6.2 gold sputter coater prior to imaging with scanning electron microscopy (SEM) using a JEOL JSM-6610 SEM. As above, all analyses were repeated n ¼ 5 times. In addition, there was one spare porous coated coupon from these tests that was autoclaved at the lowest temperature setting for a period of 30 min and imaged by SEM simply to determine if a longer autoclave time would affect the biofilm structure or presence.
Positive controls of growth were not exposed to autoclaving, but rather were fixed as described above and imaged by SEM. Negative controls of growth were the materials only without biofilm growth. Presence of biofilm was a qualitative assessment, thus statistical analyses were not performed on this portion of the study.
RESULTS
The growth protocol using the CDC reactor system provided significant and robust biofilms both on porous coated and smooth titanium surfaces (Fig. 2) . In the polymicrobial biofilm, MRSA predominated B. subtilis (Fig. 2 ), yet B. subtilis was observed in the base regions of the biofilms with evidence that it had encapsulated itself and MRSA cells in extracellular matrix materials (Fig. 3) . This supported the rationale for including B. subtilis in the experiments, which was to provide a robust extracellular matrix. MRSA FLASH AUTOCLAVING BIOFILMS biofilms did not produce matrix material that encapsulated cells, but did extend from cell to cell as has been observed previously. 29, 30 Baseline quantification data from the positive controls of growth indicated there were approximately 2.4 Â 10 9 CFU/coupon of MRSA in both the monomicrobial and polymicrobial biofilms, and 3.8 Â 10 3 CFU/ coupon for B. subtilis in the polymicrobial, which was roughly a 630,000:1 ratio of MRSA to B. subtilis, respectively. This predominance of MRSA growth corroborated with the SEM data, which provided direct, qualitative observation of biofilm growth and presence.
Only bacteria in the polymicrobial biofilm were able to survive in the lowest temperature setting and lowest duration of autoclave settings. More specifically, in the first test that was run for 5 min, biofilms were exposed to an autoclave cycle wherein the control and sterilization temperatures were the same (121˚C). Notably, with those settings, the sterilization temperature of 121˚C did not hold well in the autoclave. The temperature fluctuated and dropped below 120˚C on more than one occasion for more than 30 s at a time. Although MRSA and B. subtilis were both in the polymicrobial biofilm, only MRSA cells were found to survive on both the porous coated and smooth titanium coupons, but B. subtilis cells did not. The number of viable MRSA that were quantified from the porous coated coupons was 6.9 Â 10 1 AE 2.5 Â 10 1 CFU/ coupon. Similarly, the number of viable bacteria on the smooth coupons was 6.0 Â 10 1 AE 2.7 Â 10 1 CFU/ coupon. These outcomes were not statistically significantly different (p ¼ 0.31). When compared to the baseline controls, data indicated that biofilms of MRSA on both material types were reduced by approximately 8 log 10 units, whereas B. subtilis in the biofilms were reduced completely.
When MRSA was exposed to these autoclave settings as a monomicrobial biofilm, no viable cells were detected. Furthermore, when these settings were used and the autoclave time was increased to 10 min, all bacteria were eradicated both in the monomicrobial and polymicrobial biofilms.
In the second test, wherein the control temperature (123˚C) was set 2˚C higher than the sterilization temperature (121˚C), the autoclave held temperature and never dropped below 121˚C. No viable MRSA or B. subtilis grew by the culture method that was used at either 5 or 10 min. The same was found in the third test for coupons that were exposed to a sterilization temperature of 132˚C with a control temperature of 134˚C (sterilization temperature stayed slightly above 132˚C with these settings). However, in multiple samples across these latter two experimental groups that were run for 5 min, several isolated colonies were cultured. These were identified by an independent facility (Nelson Labs, Salt Lake City, UT) as B. licheniformis, S. epidermidis, and S. warneri. None of these isolates were cultured in the first experiment wherein the sterilization and control temperatures were the same, and these also were not identified in autoclave runs that lasted for 10 min.
Biofilms were killed in the majority of cases. However, none of the flash autoclave settings had an effect on the presence of biofilms on porous coated or smooth orthopaedic implant materials. Visually, biofilms were deflated following the autoclave cycles (Fig. 4) . When imaged by SEM, it was confirmed that biofilms had deflated, which likely occurred due to a collapse of the biofilm matrix under the heat and pressure of autoclaving, but the communities of bacteria were not removed. Indeed, all coupons were found to contain copious amounts of intact cells and matrix material of the biofilms (Fig. 5) . Even 30 min of autoclaving did not appear to affect the biofilm structure or cellular integrity (Fig. 5) .
In summary, results indicated that under the conditions specified, when the sterilization and control temperatures were the same (121˚C) and flash autoclave was performed for 5 min, viable bacterial colonies were able to be grown from intact polymicrobial biofilms. Under the same settings, monomicrobial biofilms were eradicated. When recommended flash autoclave settings were used (e.g., 132˚C and a duration of 10 min at the lower temperatures), biofilms and accompanying matrix were visually present, but did not produce viable bacterial colonies. Thus, viability data only partially supported the hypothesis that biofilms would be able to survive flash autoclaving. In contrast, the hypothesis that autoclaving would not affect the presence of biofilms on orthopaedic-relevant material was fully supported. More specifically, autoclaving at lower or higher temperatures for short or longer periods of time had no effect on the observable presence of biofilm and its accompanying matrix components. Post-autoclave, biofilms and matrix components remained intact on the surface of clinically relevant orthopaedic materials (Fig. 5) .
DISCUSSION
Flash autoclaving is one of the most common and well-established methods of sterilization both for laboratory purposes, medical implants or surgical instruments. Although it is recommended that implantable devices not be flash autoclaved, various situations may require the necessity. 14 In the CDC Guideline it is recognized that in the case of certain devices (e.g., orthopaedic screw, plate, etc.), flash sterilization may be unavoidable.
14 For a number of decades, the procedure of surgically removing an infected total joint device, flash autoclaving and re-implanting has been practiced. [8] [9] [10] [11] [31] [32] [33] [34] In the case of implant-related infection there is significant potential for biofilms to be present. 5, 6, 18, 19, 35, 36 Currently, no guidelines exist for sterilization of materials that may contain biofilms, and after literature review, it does not appear that the Figure 4 . Gross photographs of porous coated and smooth titanium coupons with biofilms after an autoclave cycle. (A) Biofilms on porous coated coupons were "deflated" and congealed in appearance compared to the positive controls prior to autoclaving. Yet their presence was still notable. (B) Biofilms likewise flattened across the surface of smooth titanium, but were still visible and notably present. This was the case following all three of the autoclave settings for both porous coated and smooth titanium coupons.
FLASH AUTOCLAVING BIOFILMS efficacy of flash autoclaving has been assessed for well-established biofilms, in particular those that may be present on the surface of titanium-based orthopaedic materials. Furthermore, it also does not appear to have been determined whether well-established biofilms have the ability to remain intact on the surface of titanium materials following flash autoclaving.
Lyons et al. have shown that autoclaving at 121˚C for 45 min was able to kill the majority of multiple bacterial species in both the planktonic and biofilm phenotypes on the surface of smooth cobalt chrome material. 17 Their data also indicated that the same autoclave cycle could remove/disperse the majority of S. aureus biofilm from the material surface. There are several points to consider from their work. The biofilm growth protocol was relatively short (24 h), did not involve shear force or renewable nutrients (which increases robustness and maturity of a biofilm), was assessed on smooth surfaces only and may not have reached a level of biofilm maturity that might be encountered clinically (biofilm formation in a patient would likely consist of multiple days if not months of growth on an implant surface). Leary et al. likewise used a similar biofilm growth method, but showed that at 121˚C and 30 min, autoclaving alone was unable to remove biofilms of S. aureus or S. epidermidis completely from smooth cobalt chrome material. 16 They showed further that the combination of autoclave, sonication, and mechanical debridement was able to more fully remove biofilm from cobalt chrome surfaces. The finding that autoclaving alone did not remove biofilms differed from the observation of Lyons et al. Future work with more mature biofilms, porous cobalt chrome structures and flash autoclave times (e.g., 10 min) may be needed to more fully consider the outcomes. Nevertheless, these studies provided a benchmark against which the current study could be compared as well as validation that the problem requires analysis.
In this study, well-established monomicrobial and polymicrobial biofilms were grown on the surface of porous coated or smooth titanium coupons. These two topographies represented clinically-relevant surface morphologies that may be present on orthopaedic devices. It was beneficial to use both surface types. Data demonstrated that surface roughness did not influence the outcomes as kill and biofilm presence were the same between both smooth and porous coated materials. In addition, 8 days of growth resulted in mature and robust biofilms.
All cells in monomicrobial biofilms were effectively killed at each of the settings and times that were assessed. Several dozen cells in the polymicrobial biofilms survived the test wherein both the control and sterilization temperatures were the same (121˚C) and flash autoclaving was performed for 5 min. These data were also collected at 10 min, which may more closely model a clinically relevant timeframe, and showed that with 10 min of autoclaving, biofilms were effectively killed. These outcomes suggest that autoclave temperatures and times may be important to review or consider in clinical settings.
It was observed that when the autoclave was set to the same control and sterilization temperatures, it failed to function normally and maintain a temperature that was lethal. When the control temperature was adjusted 2˚C higher than the sterilization temperature (to 123˚C), the autoclave held temperature and biofilms were non-viable after 5 or 10 min of autoclaving. Similarly, at the recommended temperature of 132˚C biofilms were likewise non-viable after either 5 or 10 min of autoclaving. These results may also be beneficial for facilities, hospitals, or clinics to consider. Confirmation that autoclaves are set properly may be beneficial, in particular if active biofilm is considered to be present on a material surface and is desired to be killed completely.
In the latter two settings with a 5 min duration, organisms other than MRSA or B. subtilis were cultured. It was likely that these were contaminants, but similar organisms were identified from multiple test groups. Furthermore, other experiments that were not related to this study, but run in parallel using the same aseptic techniques, showed no growth of these organisms. Multiple runs of the autoclave were also performed using blank titanium samples with no biofilms that were treated using the same procedures to confirm that contaminants did not come from the autoclave itself. No growth was detected in these cases. Although it is most likely that the outlying organisms were contaminants from the process, the observation may be worth investigating in the future.
Although biofilms may be killed by flash autoclaving, the data in this study suggested that the presence of biofilm on clinically relevant materials is not likely to be influenced by flash autoclave. This may be a particularly important point given that although bacterial cells in a biofilm can be killed following flash autoclave, residual cells of the biofilm and accompanying components on a reusable or reimplanted device could elicit unwanted or adverse immunological response, prevent osseointegration and ultimately result in implant failure. Furthermore, if non-viable biofilm components were present on a reimplanted device, this could provide a readily available "docking" location for attachment of other viable bacteria that could spread hematogenously through a patient's bloodstream. These paradigms were also noted by Leary et al. There does not appear to be clinical literature to support this, but it is recognized within the biofilm community as a risk and may warrant future investigation.
Rates of infection vary widely for revised (infected) total knee systems wherein new componentry is implanted, but on average are as low as 2%. 3 There is some indication in the literature that in clinical studies wherein flash autoclaved implants have been reimplanted in patients, rates of reoccurring infection may be slightly higher than those reported for revision surgeries wherein new implants are used. For example, Chen et al. observed a 25% rate of recurring infection in patients who were reimplanted with autoclaved femoral components of a total knee system and static spacers, and a 20% rate of recurring infection in patients who were reimplanted with an autoclaved femoral component and received a mobile spacer. 34 Kim et al. noted a 10% rate of recurrent infection in patients who were reimplanted with autoclaved femoral components. 11 Qiu et al. reimplanted both tibial and femoral components of a total knee system that were autoclaved and saw 10% rate of infection. 31 Jamsen et al. noted a relapse of infection in 12% of implants that were autoclaved and reimplanted. 33 In 50 patients Hofmann et al. reported removal, autoclaving and reimplantation of the femoral component of total knee systems. Of these, there were six (12%) recurrent infections following reimplantation. 8 Lee et al. assessed the degree of infection control and postoperative function for a new articulating spacer based on autoclaving and reimplanting the femoral component. Out of 20 patients, one (5%) suffered recurrent infection. 9 Kalore et al. retrospectively reviewed 53 patients, of which 15 received an autoclaved original component (AOC) and suggested that an AOC method would be most cost effective. Of these, 13.3% suffered recurrent infection. 10 These were general infection observations and none of the outcomes in the studies discussed were specifically reviewed or controlled for presence of biofilms. Furthermore, it is recognized that care should be taken to not overextend the findings from this in vitro study and correlate them directly to all clinical outcomes. Nevertheless, given the findings of this study and that biofilms are well-known to contribute to orthopaedic-related infections, with increased risk accompanying revision surgery due to infection, consideration should be given to reuse of implants.
In conclusion, the data suggested that autoclave settings that would be clinically relevant (e.g., 132˚C for 10 min) should be considered and reviewed for materials that are suspected to have biofilm on them as lower or fluctuating autoclave temperatures may allow biofilms to survive. The results of this study may also help direct future guideline development toward ensuring that even if biofilms are killed, that is, made non-viable, residual matrix or cellular material be taken into consideration if implantable and autoclaved materials are to be reused in the body. A combination of autoclaving, sonication, and debridement may remove biofilm more efficiently from orthopaedic materials. 16 Yet future work is needed to address the development of methods that both disperse and kill well-established, and mature biofilms that may be present on multiple material types that are smooth or porous in nature. A more conservative approach may be warranted to state that new implantable devices are required for revision procedures, in particular when infection has been a complication.
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